• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Albemarle Corporation (Amendment)

    2/9/23 10:54:52 AM ET
    $ALB
    Major Chemicals
    Industrials
    Get the next $ALB alert in real time by email
    SC 13G/A 1 tv0197-albemarlecorp.htm SCHEDULE 13G/A albemarlecorp

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G

    Under the Securities Exchange Act of 1934
    (Amendment No.: 12)*

    Name of issuer:  Albemarle Corp.

    Title of Class of Securities:  Common Stock

    CUSIP Number:  012653101

    Date of Event Which Requires Filing of this Statement: December 30, 2022

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    (Continued on the following page(s))

     

     

    13G

    CUSIP No.:  012653101

    1.  NAME OF REPORTING PERSON
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    The Vanguard Group - 23-1945930

    2.  CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP

    A. 

    B.  X

    3.  SEC USE ONLY

    4.  CITIZENSHIP OF PLACE OF ORGANIZATION

    Pennsylvania

    (For questions 5-8, report the number of shares beneficially owned by each reporting person with:)

    5.  SOLE VOTING POWER

    0

    6.  SHARED VOTING POWER

    168,628

    7.  SOLE DISPOSITIVE POWER

    13,690,202

    8.  SHARED DISPOSITIVE POWER

    484,211

    9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    14,174,413

    10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    N/A

    11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

    12.10%

    12.  TYPE OF REPORTING PERSON

    IA

     

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G
    Under the Securities Act of 1934

    Item 1(a) - Name of Issuer:

    Albemarle Corp.

    Item 1(b) - Address of Issuer's Principal Executive Offices:

    4250 Congress Street, Suite 900
    Charlotte, NC 28209

    Item 2(a) - Name of Person Filing:

    The Vanguard Group - 23-1945930

    Item 2(b) – Address of Principal Business Office or, if none, residence:

    100 Vanguard Blvd.
    Malvern, PA 19355

    Item 2(c) – Citizenship:

    Pennsylvania

    Item 2(d) - Title of Class of Securities:

    Common Stock

    Item 2(e) - CUSIP Number

    012653101

    Item 3 - Type of Filing:

    This statement is being filed pursuant to Rule 13d-1.  An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

    Item 4 - Ownership:

      (a) Amount Beneficially Owned:

      (b) Percent of Class:

     

     

    (c)  Number of shares as to which such person has:

    (i)  sole power to vote or direct to vote:  

    (ii)  shared power to vote or direct to vote:  

    (iii)  sole power to dispose of or to direct the disposition of:  

    (iv)  shared power to dispose or to direct the disposition of:  

    Comments:

    The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.  

    Item 5 - Ownership of Five Percent or Less of a Class:

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐

    Item 6 - Ownership of More Than Five Percent on Behalf of Another Person:

    The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.

    No one other person's interest in the securities reported herein is more than 5%.

    Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company:

    Not applicable

    Item 8 - Identification and Classification of Members of Group:

    Not applicable

    Item 9 - Notice of Dissolution of Group:

    Not applicable

    Item 10 - Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

    Signature

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date:  February 9, 2023

    By /s/ Ashley Grim
    Name: Ashley Grim
    Title:  Head of Global Fund Administration

    Get the next $ALB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALB

    DatePrice TargetRatingAnalyst
    2/17/2026$190.00Neutral → Buy
    BofA Securities
    1/21/2026$205.00Hold → Buy
    Truist
    1/20/2026$200.00Hold → Buy
    HSBC Securities
    1/13/2026$185.00Hold → Buy
    Deutsche Bank
    1/12/2026$200.00Sector Perform → Sector Outperform
    Scotiabank
    1/7/2026$210.00Neutral → Outperform
    Robert W. Baird
    12/16/2025$147.00Underweight → Equal-Weight
    Morgan Stanley
    12/5/2025$185.00Neutral → Buy
    UBS
    More analyst ratings

    $ALB
    SEC Filings

    View All

    SEC Form S-3ASR filed by Albemarle Corporation

    S-3ASR - ALBEMARLE CORP (0000915913) (Filer)

    3/16/26 4:29:21 PM ET
    $ALB
    Major Chemicals
    Industrials

    SEC Form PRE 14A filed by Albemarle Corporation

    PRE 14A - ALBEMARLE CORP (0000915913) (Filer)

    3/11/26 4:32:55 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Corporation filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - ALBEMARLE CORP (0000915913) (Filer)

    3/6/26 4:10:48 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Coleman Kristin M. bought $167,314 worth of shares (1,373 units at $121.86) (SEC Form 4)

    4 - ALBEMARLE CORP (0000915913) (Issuer)

    11/7/23 4:39:49 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman & CEO Masters J Kent sold $2,012,688 worth of shares (11,783 units at $170.81) and gifted 30,716 shares, decreasing direct ownership by 29% to 103,912 units (SEC Form 4)

    4 - ALBEMARLE CORP (0000915913) (Issuer)

    3/12/26 6:49:48 PM ET
    $ALB
    Major Chemicals
    Industrials

    Director Wolff Alejandro Daniel was granted 206 shares, increasing direct ownership by 2% to 12,986 units (SEC Form 4)

    4 - ALBEMARLE CORP (0000915913) (Issuer)

    3/10/26 4:16:48 PM ET
    $ALB
    Major Chemicals
    Industrials

    Chief Financial Officer Sheorey Neal Ravi was granted 4,490 shares, increasing direct ownership by 27% to 20,931 units (SEC Form 4)

    4 - ALBEMARLE CORP (0000915913) (Issuer)

    3/4/26 6:31:04 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Albemarle upgraded by BofA Securities with a new price target

    BofA Securities upgraded Albemarle from Neutral to Buy and set a new price target of $190.00

    2/17/26 8:01:23 AM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle upgraded by Truist with a new price target

    Truist upgraded Albemarle from Hold to Buy and set a new price target of $205.00

    1/21/26 8:25:13 AM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle upgraded by HSBC Securities with a new price target

    HSBC Securities upgraded Albemarle from Hold to Buy and set a new price target of $200.00

    1/20/26 8:06:42 AM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Albemarle Corporation Announces Pricing for Cash Debt Tender Offers

    CHARLOTTE, N.C., March 16, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB) (the "Company"), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced the pricing terms for its previously announced cash tender offers (each, an "Offer" and collectively, the "Offers") to purchase up to $650 million aggregate principal amount of the Notes, not including accrued and unpaid interest (an amount increased from a previously announced purchase price of $500 million), of the Company's validly tendered (and not validly withdrawn) notes set forth below (the "Notes") using a "waterfall" methodology under which the Company will accept the Notes in

    3/16/26 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Corporation Announces Early Tender Results and Upsizing of Offer Cap of Previously Announced Cash Debt Tender Offers

    CHARLOTTE, N.C., March 16, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB) (the "Company"), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced the early results of its previously announced cash tender offers (each, an "Offer" and collectively, the "Offers") for its validly tendered (and not validly withdrawn) notes set forth below (collectively, the "Notes"). The Offers are being made pursuant to an Offer to Purchase, dated March 2, 2026 (as amended and supplemented hereby, the "Offer to Purchase"), which sets forth a description of the terms of the Offers.

    3/16/26 6:50:00 AM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Appoints Michelle T. Collins and Mark R. Widmar to Board of Directors

    CHARLOTTE, N.C., March 2, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced that its Board of Directors (the "Board") has appointed Michelle T. Collins and Mark R. Widmar to the Board, effective February 26, 2026. Collins will join the Board's Audit & Finance Committee and Governance & Public Policy Committee. Widmar will join the Executive Compensation & Talent Development Committee and Safety, Sustainability, Operations & Capital Committee. Collins brings more t

    3/2/26 4:40:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Leadership Updates

    Live Leadership Updates

    View All

    Albemarle Appoints Michelle T. Collins and Mark R. Widmar to Board of Directors

    CHARLOTTE, N.C., March 2, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced that its Board of Directors (the "Board") has appointed Michelle T. Collins and Mark R. Widmar to the Board, effective February 26, 2026. Collins will join the Board's Audit & Finance Committee and Governance & Public Policy Committee. Widmar will join the Executive Compensation & Talent Development Committee and Safety, Sustainability, Operations & Capital Committee. Collins brings more t

    3/2/26 4:40:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Ketjen Announces the Appointment of Henri Tausch as Chief Commercial Officer

    Ketjen Corporation, a leader in catalyst and specialty chemicals manufacturing, today announces the appointment of Henri Tausch to Chief Commercial Officer (CCO) effective June 24, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240619765799/en/Henri Tausch, Ketjen Chief Commercial Officer (Photo: Business Wire) In his role as Chief Commercial Officer, Tausch will oversee and advance the company's commercial strategy, and foster key partnerships to accelerate the company's global growth trajectory. "I am honored to join Ketjen and contribute to its continued success," said Henri Tausch "It's inspiring to see Ketjen's dedi

    6/19/24 7:00:00 AM ET
    $ALB
    Major Chemicals
    Industrials

    International Paper Announces Changes to Its Board of Directors

     Jamie A. Beggs and Scott A. Tozier to Join as Newest Board Members Ilene S. Gordon to Retire from the Board MEMPHIS, Tenn., May 22, 2024 /PRNewswire/ -- International Paper ("IP") (NYSE:IP) announced that Jamie A. Beggs and Scott A. Tozier have been elected to IP's Board of Directors, effective May 21, 2024. The company also announced that Ilene S. Gordon has retired from the Board citing personal and health reasons, effective May 21, 2024. Ms. Beggs, age 47, currently serves as Senior Vice President and Chief Financial Officer of Avient Corporation (NYSE:AVNT), a premier pr

    5/23/24 10:51:00 AM ET
    $ALB
    $AVNT
    $IP
    Major Chemicals
    Industrials
    Paper
    Basic Materials

    $ALB
    Financials

    Live finance-specific insights

    View All

    Albemarle Announces Quarterly Common Stock Dividend

    CHARLOTTE, N.C., Feb. 26, 2026 /PRNewswire/ -- The Board of Directors of Albemarle Corporation (NYSE:ALB) today announced that it declared a quarterly common stock dividend of $0.405 per share. The dividend, which has an annualized rate of $1.62, is payable April 1, 2026, to shareholders of record at the close of business as of March 13, 2026. About Albemarle Albemarle Corporation (NYSE:ALB) leads the world in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. We partner to pioneer new ways to move, power, connect and protec

    2/26/26 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Announces Plans to Idle its Kemerton Lithium Hydroxide Processing Plant

    Decision improves financial flexibility and preserves optionality CHARLOTTE, N.C., Feb. 11, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced it will idle the remaining operating train, Train 1, at its Kemerton lithium hydroxide processing plant in Western Australia and place it into care and maintenance effective immediately. Today's announcement follows actions in 2024 to place Train 2 into care and maintenance and to cease expansion plans for Trains 3 and 4.

    2/11/26 4:20:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Reports Fourth Quarter and Full Year 2025 Results

    CHARLOTTE, N.C., Feb. 11, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter and Full Year 2025 Results and Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Fourth quarter net sales of $1.4 billion, up 16%; volume up 12%, including gains in all segments led by Energy Storage (up 17%) and Ketjen (up 13%).Fourth quarter net loss of

    2/11/26 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Albemarle Corporation

    SC 13G/A - ALBEMARLE CORP (0000915913) (Subject)

    12/5/24 7:27:01 PM ET
    $ALB
    Major Chemicals
    Industrials

    SEC Form SC 13G filed by Albemarle Corporation

    SC 13G - ALBEMARLE CORP (0000915913) (Subject)

    11/13/24 12:52:42 PM ET
    $ALB
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Albemarle Corporation

    SC 13G/A - ALBEMARLE CORP (0000915913) (Subject)

    11/13/24 10:27:59 AM ET
    $ALB
    Major Chemicals
    Industrials